| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 749 |
| Total Expenses - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.726 |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.977 |
| Net Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.977 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Farmaplus Gie
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 4.872 | 4.822 | 4.741 | 4.654 | 4.564 | 4.477 | 4.378 | 4.391 | 4.378 | 297 |
| Inventories | 786 | 778 | 765 | 751 | 736 | 722 | 706 | 708 | 706 | 0 |
| Receivables | 3.754 | 3.716 | 3.653 | 3.586 | 3.516 | 3.450 | 3.373 | 3.384 | 3.373 | 0 |
| Cash | 332 | 329 | 323 | 317 | 311 | 305 | 299 | 300 | 299 | 297 |
| Shareholders Funds | 4.783 | 4.734 | 4.654 | 4.569 | 4.480 | 4.395 | 4.298 | 4.311 | 4.298 | 297 |
| Social Capital | 787 | 779 | 766 | 752 | 738 | 724 | 708 | 710 | 708 | 704 |
| Debts | 89 | 88 | 86 | 85 | 83 | 82 | 80 | 80 | 80 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6421 - 6421" | |||||||||
| CAEN Financial Year |
6420
|
|||||||||
Comments - Farmaplus Gie